Tachykinin-1 receptor stimulates proinflammatory gene expression in lung epithelial cells through activation of NF-κB via a Gq-dependent pathway
Authors:
Open Access
- 1 February 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 292 (2) , L430-L437
Abstract
The respiratory tract is innervated by irritant-responsive sensory nerves, which, on stimulation, release tachykinin neuropeptides in the lung. Tachykinins modulate inflammatory responses to injury by binding to tachykinin (neurokinin) receptors present on various pulmonary cell types. In the present study, the activation of the proinflammatory transcription factor NF-κB in lung epithelial cells was investigated as a mechanism by which tachykinins stimulate inflammatory processes. In A549 human lung epithelial cells transfected with the tachykinin-1 receptor (Tacr1), treatment with the Tacr1 ligand substance P (SP) resulted in NF-κB activation, as judged by transcription of an NF-κB-luciferase reporter gene and production of interleukin-8, a chemokine whose expression is upregulated by NF-κB. SP caused a dose-dependent activation of NF-κB that was inhibited by the selective Tacr1 antagonist RP67580. Tacr1 is a G protein-coupled receptor capable of activating both the Gqand Gsfamilies of G proteins. Expression of inhibitory peptides and constitutively active G protein mutants revealed that Gqsignaling was both necessary for Tacr1-induced NF-κB activation and sufficient for NF-κB activation in the absence of any other treatment. Treatment with pharmacological inhibitors to investigate events downstream of Gqrevealed that Tacr1-induced NF-κB activation proceeded through an intracellular signaling pathway that was dependent on phospholipase C, calcium, Ras, Raf-1, MEK, Erk, and proteasome function. These results identify intracellular signaling mechanisms that underlie the proinflammatory effects of tachykinins, which previously have been implicated in lung injury and disease.Keywords
This publication has 35 references indexed in Scilit:
- Hypoxia upregulates lung microvascular neurokinin-1 receptor expressionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF‐κB pathwayBritish Journal of Pharmacology, 2005
- Gα Minigenes Expressing C-terminal Peptides Serve as Specific Inhibitors of Thrombin-mediated Endothelial ActivationJournal of Biological Chemistry, 2001
- Two Active Molecular Phenotypes of the Tachykinin NK1 Receptor Revealed by G-protein Fusions and MutagenesisJournal of Biological Chemistry, 2001
- Substance P and its receptor neurokinin 1 expression in asthmatic airwaysJournal of Allergy and Clinical Immunology, 2000
- Substance P activates NF-κB independent of elevations in intracellular calcium in murine macrophages and dendritic cellsJournal of Neuroimmunology, 2000
- A Dominant-Negative Strategy for Studying Roles of G Proteins in VivoJournal of Biological Chemistry, 1999
- Increased mitogenic responsiveness of Swiss 3T3 cells expressing constitutively active GsαBiochemical and Biophysical Research Communications, 1990
- Effect of Neuropeptides on Production of Inflammatory Cytokines by Human MonocytesScience, 1988
- Leakage of macromolecules from guinea‐pig tracheobronchial microcirculation. Effects of allergen, leukotrienes, tachykinins, and anti‐asthma drugsActa Physiologica Scandinavica, 1986